ROCKLAGE SCOTT M

10% owner at Skye Bioscience, Inc. · on record since Aug 28, 2023
Director at CUBIST PHARMACEUTICALS INC · on record since Jul 1, 2003
Director at Relypsa Inc · on record since Nov 20, 2013
10% owner at Relypsa Inc · on record since Nov 20, 2013
Director at Achaogen, Inc. · on record since Mar 13, 2014
10% owner at VIVEVE MEDICAL, INC. · on record since Sep 25, 2014
Director at Enterprise Informatics Inc · on record since Jul 15, 2014
10% owner at Enterprise Informatics Inc · on record since Sep 3, 2014
Director at Pulmatrix, Inc. · on record since Jun 25, 2015
Director at Cidara Therapeutics, Inc. · on record since Apr 22, 2015
10% owner at Cidara Therapeutics, Inc. · on record since Apr 22, 2015
10% owner at PHASERX, INC. · on record since May 23, 2016
10% owner at LOT78, INC. · on record since Jul 19, 2016
former 10% owner at LOT78, INC. · on record since Apr 26, 2017
10% owner at scPharmaceuticals Inc. · on record since Nov 21, 2017
10% owner at Q32 Bio Inc. · on record since Mar 27, 2018
10% owner at ARVINAS, INC. · on record since Sep 26, 2018
10% owner at Crinetics Pharmaceuticals, Inc. · on record since Jul 20, 2018
10% owner at · on record since May 28, 2019
Former 10% holder at · on record since Jun 25, 2019
10% owner at · on record since Oct 31, 2019
Director at · on record since Oct 7, 2019
10% owner at · on record since Jun 25, 2020
10% owner at · on record since Jun 18, 2020
Former 10% holder at · on record since Oct 7, 2020
10% owner at · on record since Jul 29, 2021
10% owner at · on record since Apr 29, 2021
10% owner at · on record since Oct 28, 2021
10% owner at · on record since Dec 13, 2021

Insider trading activity of ROCKLAGE SCOTT M

Transactions on record: 225; since Aug 27, 2003

Open-market buys: 10; $8.6M

Open-market sells: 28; $49M

Companies traded: 13; last filing Aug 22, 2025

Figures computed from official regulatory filings — .

Companies where ROCKLAGE SCOTT M has traded

4 tx · $800.5K · Aug 22, 2025
1 tx · Apr 26, 2021
4 tx · $5M · Jan 12, 2021
15 tx · $20M · Jul 1, 2020
14 tx · $11.3M · Jun 25, 2019
4 tx · $13.6M · May 20, 2019
8 tx · Jun 15, 2018
11 tx · $267K · Feb 25, 2016
3 tx · $2M · Jun 8, 2015
2 tx · $250K · May 29, 2015
1 tx · Mar 13, 2014
80 tx · $5M · Nov 20, 2013
78 tx · $1.6M · Dec 2, 2004

Track record of ROCKLAGE SCOTT M

Statistical track record

Free account

Open-market buys: 10

Last buy: Jul 20, 2018

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of ROCKLAGE SCOTT M

Co-insiders of ROCKLAGE SCOTT M

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Skye Bioscience, Inc.Listing on record	Aug 22, 2025	Sell	-163,979	3.42 USD	$560.8K	SEC
Skye Bioscience, Inc.Listing on record	Aug 22, 2025	Sell	-2,314	3.57 USD	$8.3K	SEC
Skye Bioscience, Inc.Listing on record	Aug 22, 2025	Sell	-58,642	3.57 USD	$209.4K	SEC
Skye Bioscience, Inc.Listing on record	Aug 22, 2025	Sell	-6,470	3.42 USD	$22.1K	SEC
IPI Legacy Liquidation CoListing unverified	Apr 26, 2021	OtherD (derivative)	1,359,799.28	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Cabaletta Bio, Inc.Listing on record	Jan 12, 2021	Sell	-74,470	13.00 USD	$968.1K	SEC
Cabaletta Bio, Inc.Listing on record	Jan 12, 2021	Sell	-264,589	13.00 USD	$3.4M	SEC
Cabaletta Bio, Inc.Listing on record	Jan 12, 2021	Sell	-37,411	13.00 USD	$486.3K	SEC
Cabaletta Bio, Inc.Listing on record	Jan 12, 2021	Sell	-10,530	13.00 USD	$136.9K	SEC
Aprea Therapeutics, Inc.Listing on record	Jul 1, 2020	AwardD (derivative)	5,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aprea Therapeutics, Inc.Listing on record	Jun 18, 2020	Sell	-4,807	33.30 USD	$160.1K	SEC
Aprea Therapeutics, Inc.Listing on record	Jun 18, 2020	Sell	-115,357	33.30 USD	$3.8M	SEC
Aprea Therapeutics, Inc.Listing on record	Jun 15, 2020	Sell	-235,200	28.75 USD	$6.8M	SEC
Aprea Therapeutics, Inc.Listing on record	Jun 15, 2020	Sell	-9,800	28.75 USD	$281.8K	SEC
Aprea Therapeutics, Inc.Listing on record	May 21, 2020	Sell	-244,800	35.15 USD	$8.6M	SEC
Aprea Therapeutics, Inc.Listing on record	May 21, 2020	Sell	-10,200	35.15 USD	$358.5K	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	Other	79,746	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-20,519	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	Other	1,913,910	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-79,746	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	Other	492,475	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	Other	20,519	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-1,913,910	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-492,475	—	n/a (No price was disclosed in the filing)	SEC
Crinetics Pharmaceuticals, Inc.Listing on record	Jun 25, 2019	Sell	-240,000	22.20 USD	$5.3M	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Skye Bioscience, Inc.Listing on record	Aug 22, 2025	Sell	-163,979	3.42 USD	$560.8K	SEC
Skye Bioscience, Inc.Listing on record	Aug 22, 2025	Sell	-2,314	3.57 USD	$8.3K	SEC
Skye Bioscience, Inc.Listing on record	Aug 22, 2025	Sell	-58,642	3.57 USD	$209.4K	SEC
Skye Bioscience, Inc.Listing on record	Aug 22, 2025	Sell	-6,470	3.42 USD	$22.1K	SEC
IPI Legacy Liquidation CoListing unverified	Apr 26, 2021	OtherD (derivative)	1,359,799.28	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Cabaletta Bio, Inc.Listing on record	Jan 12, 2021	Sell	-74,470	13.00 USD	$968.1K	SEC
Cabaletta Bio, Inc.Listing on record	Jan 12, 2021	Sell	-264,589	13.00 USD	$3.4M	SEC
Cabaletta Bio, Inc.Listing on record	Jan 12, 2021	Sell	-37,411	13.00 USD	$486.3K	SEC
Cabaletta Bio, Inc.Listing on record	Jan 12, 2021	Sell	-10,530	13.00 USD	$136.9K	SEC
Aprea Therapeutics, Inc.Listing on record	Jul 1, 2020	AwardD (derivative)	5,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Aprea Therapeutics, Inc.Listing on record	Jun 18, 2020	Sell	-4,807	33.30 USD	$160.1K	SEC
Aprea Therapeutics, Inc.Listing on record	Jun 18, 2020	Sell	-115,357	33.30 USD	$3.8M	SEC
Aprea Therapeutics, Inc.Listing on record	Jun 15, 2020	Sell	-235,200	28.75 USD	$6.8M	SEC
Aprea Therapeutics, Inc.Listing on record	Jun 15, 2020	Sell	-9,800	28.75 USD	$281.8K	SEC
Aprea Therapeutics, Inc.Listing on record	May 21, 2020	Sell	-244,800	35.15 USD	$8.6M	SEC
Aprea Therapeutics, Inc.Listing on record	May 21, 2020	Sell	-10,200	35.15 USD	$358.5K	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	Other	79,746	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-20,519	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	Other	1,913,910	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-79,746	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	Other	492,475	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	Other	20,519	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-1,913,910	—	n/a (No price was disclosed in the filing)	SEC
Aprea Therapeutics, Inc.Listing on record	Oct 7, 2019	OtherD (derivative)	-492,475	—	n/a (No price was disclosed in the filing)	SEC
Crinetics Pharmaceuticals, Inc.Listing on record	Jun 25, 2019	Sell	-240,000	22.20 USD	$5.3M	SEC